65
Participants
Start Date
June 30, 2015
Primary Completion Date
January 31, 2018
Study Completion Date
February 28, 2018
Ezogabine
Potiga is FDA-approved for adjunctive treatment of partial-onset seizures in patients aged 18 years and older who have responded inadequately to several alternative treatments.
Placebo
Matched placebo
Hospital for Special Surgery, New York
Penn State College of Medicine Milton S. Hershey Medical Center, Hershey
Johns Hopkins Hospital, Baltimore
Duke University Hospital, Durham
Augusta University (Georgia Regents Medical Center), Augusta
Mayo Clinic in Florida, Jacksonville
University of Michigan, Ann Arbor
Barrow Neuological Institute, Phoenix
Cedars-Sinai, Los Angeles
UC Irvine Medical Center, Orange
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Collaborators (1)
ALS Association
OTHER
GlaxoSmithKline
INDUSTRY
Harvard University
OTHER
Massachusetts General Hospital
OTHER
Brian Wainger
OTHER